Loading…
Flavivirus DNA vaccines: current status and potential
The use of DNA-based vaccines is a novel and promising immunization approach for the development of flavivirus vaccines. This approach has been attempted in vaccine development for various virus species, including St. Louis encephalitis, Russian spring-summer encephalitis, Central European encephali...
Saved in:
Published in: | Annals of the New York Academy of Sciences 2001-12, Vol.951 (1), p.272-285 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c258t-74c30c16666c45987ec650116f23218438f13ab36ff85b9af4e10b5518f23d753 |
container_end_page | 285 |
container_issue | 1 |
container_start_page | 272 |
container_title | Annals of the New York Academy of Sciences |
container_volume | 951 |
creator | Chang, G J Davis, B S Hunt, A R Holmes, D A Kuno, G |
description | The use of DNA-based vaccines is a novel and promising immunization approach for the development of flavivirus vaccines. This approach has been attempted in vaccine development for various virus species, including St. Louis encephalitis, Russian spring-summer encephalitis, Central European encephalitis, dengue serotypes 1 and 2, Murray Valley encephalitis, Japanese encephalitis, and West Nile viruses. However, very little is known about the factors affecting its efficacy. Recently, we demonstrated that a single intramuscular immunization of DNA vaccine of Japanese encephalitis and West Nile viruses protected mice and horses from virus challenge. Administration of these recombinant plasmid vectors resulted in endogenous expression and secretion of extracellular virus-like particles that correlated well with the induction of protective immunity. These results provided evidence that the virus-like particles composed of premembrane/membrane and envelope proteins are essential for eliciting immune responses similar to those induced by live, attenuated virus vaccines. The biosynthesis and protein processing of premembrane/membrane and envelope proteins that preserve the native conformation and glycosylation profiles identical to virion proteins could be determined by the effectiveness of the transmembrane signal sequence located at the amino-terminus of premembrane protein. The use of DNA vaccines in multivalent and/or combination vaccines designed to immunize against multiple flaviviruses is also a promising area of development. |
doi_str_mv | 10.1111/j.1749-6632.2001.tb02703.x |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72404770</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72404770</sourcerecordid><originalsourceid>FETCH-LOGICAL-c258t-74c30c16666c45987ec650116f23218438f13ab36ff85b9af4e10b5518f23d753</originalsourceid><addsrcrecordid>eNpFkM1OwzAQhC0EoqXwCijiwC3B65_Y6a1qKSBVcIGz5biOlCpNiu1U5e1x1Aj2stLOzK72Q-gBcAaxnnYZCFakeU5JRjCGLJSYCEyz0wWa_kmXaIqxEKksCJ2gG-930UokE9doAiAKISSbIr5u9LE-1q73yep9kRy1MXVr_TwxvXO2DYkPOkRRt9vk0IU4qXVzi64q3Xh7N_YZ-lo_fy5f083Hy9tysUkN4TKkghmKDeSxDOOFFNbkHAPkFaEEJKOyAqpLmleV5GWhK2YBl5yDjIat4HSGHs97D6777q0Pal97Y5tGt7brvRKEYSbi6zM0PxuN67x3tlIHV--1-1GA1QBN7dRARg1k1ABNjdDUKYbvxyt9ubfb_-hIif4Cln9n7A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72404770</pqid></control><display><type>article</type><title>Flavivirus DNA vaccines: current status and potential</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Chang, G J ; Davis, B S ; Hunt, A R ; Holmes, D A ; Kuno, G</creator><creatorcontrib>Chang, G J ; Davis, B S ; Hunt, A R ; Holmes, D A ; Kuno, G</creatorcontrib><description>The use of DNA-based vaccines is a novel and promising immunization approach for the development of flavivirus vaccines. This approach has been attempted in vaccine development for various virus species, including St. Louis encephalitis, Russian spring-summer encephalitis, Central European encephalitis, dengue serotypes 1 and 2, Murray Valley encephalitis, Japanese encephalitis, and West Nile viruses. However, very little is known about the factors affecting its efficacy. Recently, we demonstrated that a single intramuscular immunization of DNA vaccine of Japanese encephalitis and West Nile viruses protected mice and horses from virus challenge. Administration of these recombinant plasmid vectors resulted in endogenous expression and secretion of extracellular virus-like particles that correlated well with the induction of protective immunity. These results provided evidence that the virus-like particles composed of premembrane/membrane and envelope proteins are essential for eliciting immune responses similar to those induced by live, attenuated virus vaccines. The biosynthesis and protein processing of premembrane/membrane and envelope proteins that preserve the native conformation and glycosylation profiles identical to virion proteins could be determined by the effectiveness of the transmembrane signal sequence located at the amino-terminus of premembrane protein. The use of DNA vaccines in multivalent and/or combination vaccines designed to immunize against multiple flaviviruses is also a promising area of development.</description><identifier>ISSN: 0077-8923</identifier><identifier>EISSN: 1749-6632</identifier><identifier>DOI: 10.1111/j.1749-6632.2001.tb02703.x</identifier><identifier>PMID: 11797784</identifier><language>eng</language><publisher>United States</publisher><subject>Amino Acid Sequence ; Animals ; Flavivirus - genetics ; Flavivirus Infections - prevention & control ; Gene Expression Regulation, Viral ; Humans ; Mice ; Molecular Sequence Data ; Vaccines, DNA ; West Nile Fever - prevention & control</subject><ispartof>Annals of the New York Academy of Sciences, 2001-12, Vol.951 (1), p.272-285</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c258t-74c30c16666c45987ec650116f23218438f13ab36ff85b9af4e10b5518f23d753</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11797784$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chang, G J</creatorcontrib><creatorcontrib>Davis, B S</creatorcontrib><creatorcontrib>Hunt, A R</creatorcontrib><creatorcontrib>Holmes, D A</creatorcontrib><creatorcontrib>Kuno, G</creatorcontrib><title>Flavivirus DNA vaccines: current status and potential</title><title>Annals of the New York Academy of Sciences</title><addtitle>Ann N Y Acad Sci</addtitle><description>The use of DNA-based vaccines is a novel and promising immunization approach for the development of flavivirus vaccines. This approach has been attempted in vaccine development for various virus species, including St. Louis encephalitis, Russian spring-summer encephalitis, Central European encephalitis, dengue serotypes 1 and 2, Murray Valley encephalitis, Japanese encephalitis, and West Nile viruses. However, very little is known about the factors affecting its efficacy. Recently, we demonstrated that a single intramuscular immunization of DNA vaccine of Japanese encephalitis and West Nile viruses protected mice and horses from virus challenge. Administration of these recombinant plasmid vectors resulted in endogenous expression and secretion of extracellular virus-like particles that correlated well with the induction of protective immunity. These results provided evidence that the virus-like particles composed of premembrane/membrane and envelope proteins are essential for eliciting immune responses similar to those induced by live, attenuated virus vaccines. The biosynthesis and protein processing of premembrane/membrane and envelope proteins that preserve the native conformation and glycosylation profiles identical to virion proteins could be determined by the effectiveness of the transmembrane signal sequence located at the amino-terminus of premembrane protein. The use of DNA vaccines in multivalent and/or combination vaccines designed to immunize against multiple flaviviruses is also a promising area of development.</description><subject>Amino Acid Sequence</subject><subject>Animals</subject><subject>Flavivirus - genetics</subject><subject>Flavivirus Infections - prevention & control</subject><subject>Gene Expression Regulation, Viral</subject><subject>Humans</subject><subject>Mice</subject><subject>Molecular Sequence Data</subject><subject>Vaccines, DNA</subject><subject>West Nile Fever - prevention & control</subject><issn>0077-8923</issn><issn>1749-6632</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNpFkM1OwzAQhC0EoqXwCijiwC3B65_Y6a1qKSBVcIGz5biOlCpNiu1U5e1x1Aj2stLOzK72Q-gBcAaxnnYZCFakeU5JRjCGLJSYCEyz0wWa_kmXaIqxEKksCJ2gG-930UokE9doAiAKISSbIr5u9LE-1q73yep9kRy1MXVr_TwxvXO2DYkPOkRRt9vk0IU4qXVzi64q3Xh7N_YZ-lo_fy5f083Hy9tysUkN4TKkghmKDeSxDOOFFNbkHAPkFaEEJKOyAqpLmleV5GWhK2YBl5yDjIat4HSGHs97D6777q0Pal97Y5tGt7brvRKEYSbi6zM0PxuN67x3tlIHV--1-1GA1QBN7dRARg1k1ABNjdDUKYbvxyt9ubfb_-hIif4Cln9n7A</recordid><startdate>200112</startdate><enddate>200112</enddate><creator>Chang, G J</creator><creator>Davis, B S</creator><creator>Hunt, A R</creator><creator>Holmes, D A</creator><creator>Kuno, G</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200112</creationdate><title>Flavivirus DNA vaccines: current status and potential</title><author>Chang, G J ; Davis, B S ; Hunt, A R ; Holmes, D A ; Kuno, G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c258t-74c30c16666c45987ec650116f23218438f13ab36ff85b9af4e10b5518f23d753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Amino Acid Sequence</topic><topic>Animals</topic><topic>Flavivirus - genetics</topic><topic>Flavivirus Infections - prevention & control</topic><topic>Gene Expression Regulation, Viral</topic><topic>Humans</topic><topic>Mice</topic><topic>Molecular Sequence Data</topic><topic>Vaccines, DNA</topic><topic>West Nile Fever - prevention & control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chang, G J</creatorcontrib><creatorcontrib>Davis, B S</creatorcontrib><creatorcontrib>Hunt, A R</creatorcontrib><creatorcontrib>Holmes, D A</creatorcontrib><creatorcontrib>Kuno, G</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of the New York Academy of Sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chang, G J</au><au>Davis, B S</au><au>Hunt, A R</au><au>Holmes, D A</au><au>Kuno, G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Flavivirus DNA vaccines: current status and potential</atitle><jtitle>Annals of the New York Academy of Sciences</jtitle><addtitle>Ann N Y Acad Sci</addtitle><date>2001-12</date><risdate>2001</risdate><volume>951</volume><issue>1</issue><spage>272</spage><epage>285</epage><pages>272-285</pages><issn>0077-8923</issn><eissn>1749-6632</eissn><abstract>The use of DNA-based vaccines is a novel and promising immunization approach for the development of flavivirus vaccines. This approach has been attempted in vaccine development for various virus species, including St. Louis encephalitis, Russian spring-summer encephalitis, Central European encephalitis, dengue serotypes 1 and 2, Murray Valley encephalitis, Japanese encephalitis, and West Nile viruses. However, very little is known about the factors affecting its efficacy. Recently, we demonstrated that a single intramuscular immunization of DNA vaccine of Japanese encephalitis and West Nile viruses protected mice and horses from virus challenge. Administration of these recombinant plasmid vectors resulted in endogenous expression and secretion of extracellular virus-like particles that correlated well with the induction of protective immunity. These results provided evidence that the virus-like particles composed of premembrane/membrane and envelope proteins are essential for eliciting immune responses similar to those induced by live, attenuated virus vaccines. The biosynthesis and protein processing of premembrane/membrane and envelope proteins that preserve the native conformation and glycosylation profiles identical to virion proteins could be determined by the effectiveness of the transmembrane signal sequence located at the amino-terminus of premembrane protein. The use of DNA vaccines in multivalent and/or combination vaccines designed to immunize against multiple flaviviruses is also a promising area of development.</abstract><cop>United States</cop><pmid>11797784</pmid><doi>10.1111/j.1749-6632.2001.tb02703.x</doi><tpages>14</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0077-8923 |
ispartof | Annals of the New York Academy of Sciences, 2001-12, Vol.951 (1), p.272-285 |
issn | 0077-8923 1749-6632 |
language | eng |
recordid | cdi_proquest_miscellaneous_72404770 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Amino Acid Sequence Animals Flavivirus - genetics Flavivirus Infections - prevention & control Gene Expression Regulation, Viral Humans Mice Molecular Sequence Data Vaccines, DNA West Nile Fever - prevention & control |
title | Flavivirus DNA vaccines: current status and potential |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T10%3A02%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Flavivirus%20DNA%20vaccines:%20current%20status%20and%20potential&rft.jtitle=Annals%20of%20the%20New%20York%20Academy%20of%20Sciences&rft.au=Chang,%20G%20J&rft.date=2001-12&rft.volume=951&rft.issue=1&rft.spage=272&rft.epage=285&rft.pages=272-285&rft.issn=0077-8923&rft.eissn=1749-6632&rft_id=info:doi/10.1111/j.1749-6632.2001.tb02703.x&rft_dat=%3Cproquest_cross%3E72404770%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c258t-74c30c16666c45987ec650116f23218438f13ab36ff85b9af4e10b5518f23d753%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=72404770&rft_id=info:pmid/11797784&rfr_iscdi=true |